AIG
SGMO

American International Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

American International Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-73,421
Closed -$49.2K – 2265
2024
Q1 		$49.2K Sell
73,421
-630
-0.9% -$457 ﹤0.01% 2784
2023
Q4 		$40.2K Buy
74,051
+2,068
+3% +$953 ﹤0.01% 2863
2023
Q3 		$43.2K Buy
71,983
+2,560
+4% +$2.74K ﹤0.01% 2852
2023
Q2 		$90.3K Buy
69,423
+4,840
+7% +$6.61K ﹤0.01% 2653
2023
Q1 		$114K Buy
64,583
+1,285
+2% +$3.67K ﹤0.01% 2398
2022
Q4 		$199K Buy
63,298
+2,610
+4% +$10.1K ﹤0.01% 2131
2022
Q3 		$297K Buy
60,688
+4,627
+8% +$23.8K ﹤0.01% 1914
2022
Q2 		$232K Sell
56,061
-2,891
-5% -$12.5K ﹤0.01% 2094
2022
Q1 		$343K Sell
58,952
-4,149
-7% -$24.7K ﹤0.01% 1932
2021
Q4 		$473K Sell
63,101
-1,888
-3% -$16.4K ﹤0.01% 1849
2021
Q3 		$586K Sell
64,989
-878
-1% -$8.68K ﹤0.01% 1749
2021
Q2 		$788 Sell
65,867
-1,245
-2% -$14.1K ﹤0.01% 1643
2021
Q1 		$841 Buy
67,112
+177
+0.3% +$2.38K ﹤0.01% 1553
2020
Q4 		$1.04K Sell
66,935
-1,920
-3% -$22.5K ﹤0.01% 1355
2020
Q3 		$651K Sell
68,855
-1,566
-2% -$16.9K ﹤0.01% 1461
2020
Q2 		$631K Buy
70,421
+2,417
+4% +$22.4K ﹤0.01% 1481
2020
Q1 		$433K Sell
68,004
-3,928
-5% -$29.1K ﹤0.01% 1502
2019
Q4 		$602K Sell
71,932
-605
-0.8% -$5.56K ﹤0.01% 1594
2019
Q3 		$656K Sell
72,537
-505
-0.7% -$5.67K ﹤0.01% 1515
2019
Q2 		$787K Buy
73,042
+8,370
+13% +$89K ﹤0.01% 1450
2019
Q1 		$617K Sell
64,672
-2,096
-3% -$21.4K ﹤0.01% 1586
2018
Q4 		$766K Sell
66,768
-514
-0.8% -$6.38K ﹤0.01% 1420
2018
Q3 		$1.14M Buy
67,282
+1,212
+2% +$18.4K ﹤0.01% 1361
2018
Q2 		$938K Buy
66,070
+12,473
+23% +$207K ﹤0.01% 1427
2018
Q1 		$1.02M Sell
53,597
-2,884
-5% -$61.7K ﹤0.01% 1264
2017
Q4 		$926K Buy
56,481
+1,440
+3% +$21.4K ﹤0.01% 1410
2017
Q3 		$826K Buy
55,041
+10,773
+24% +$119K ﹤0.01% 1458
2017
Q2 		$390K Buy
44,268
+1,521
+4% +$9.76K ﹤0.01% 1871
2017
Q1 		$222K Buy
42,747
+2,818
+7% +$11.3K ﹤0.01% 2115
2016
Q4 		$122K Sell
39,929
-103
-0.3% -$375 ﹤0.01% 2484
2016
Q3 		$185K Buy
40,032
+61
+0.2% +$310 ﹤0.01% 2218
2016
Q2 		$231K Sell
39,971
-782
-2% -$4.98K ﹤0.01% 2040
2016
Q1 		$247K Hold
40,753
– – ﹤0.01% 2578
2015
Q4 		$372K Sell
40,753
-71
-0.2% -$547 ﹤0.01% 2272
2015
Q3 		$230K Buy
40,824
+48
+0.1% +$396 ﹤0.01% 2682
2015
Q2 		$452K Sell
40,776
-1,956
-5% -$25.2K ﹤0.01% 2280
2015
Q1 		$670K Hold
42,732
– – ﹤0.01% 1924
2014
Q4 		$650K Sell
42,732
-1,690
-4% -$20.5K ﹤0.01% 1908
2014
Q3 		$479K Sell
44,422
-33
-0.1% -$431 ﹤0.01% 2187
2014
Q2 		$679K Buy
44,455
+1,983
+5% +$28.5K ﹤0.01% 1912
2014
Q1 		$768K Buy
42,472
+996
+2% +$19.2K ﹤0.01% 1762
2013
Q4 		$576K Buy
41,476
+4,257
+11% +$49K ﹤0.01% 1927
2013
Q3 		$390K Sell
37,219
-191
-0.5% -$1.9K ﹤0.01% 2154
2013
Q2 		$292K Buy
+37,410
New +$326K ﹤0.01% 2249

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

American International Group's SGMO Position: Q2 2024 in Review

American International Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2024, closing a stake of 73,421 shares — an estimated $49.2K sold.

American International Group first reported a position in SGMO in Q2 2013 and held it in 44 quarters. The position peaked at $1.14M in Q3 2018. 129 funds tracked by Wall St. Rank hold SGMO as of Q2 2024.

  • American International Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 73,421 SANGAMO THERAPEUTICS INC shares in Q2 2024, an estimated $49.2K.
  • American International Group first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 44 quarters.
  • American International Group's SANGAMO THERAPEUTICS INC position peaked at $1.14M in Q3 2018.
  • 129 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.